Neuroblastoma | CHOP Research Institute

In the News: Big Data Analysis, High-risk Neuroblastoma, D3b Supports Tumor Sample Milestone

Published on

Apr 14, 2023

Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.

Wolpaw Laboratory

Dr. Wolpaw’s laboratory seeks to develop an understanding of how tumor heterogeneity and epigenetics impact inflammatory signaling and immunotherapy responses in pediatric solid tumors with a goal of developing more efficacious, less toxic therapies to treat these devastating diseases.

Where Discovery Leads: Taking CAR T-Cell Therapy to Solid Tumors and Beyond

Published on

Sep 19, 2022

in Cornerstone Blog

Where Discovery Leads: CAR T-Cell Therapy Research

CHOP physician-scientists discuss their CAR T-cell therapy research for childhood cancers in Where Discovery Leads.

Nicholas F. Evageliou, MD

Dr. Evageliou is an attending physician in the Division of Oncology. His research interest is in renal tumors, neuroblastoma, and solid tumors. He is a member of the Renal Tumors Committee of the Children's Oncology Group, where he helps create clinical trials for Wilms tumors.

E-mail:

evageliou [at] chop.edu

CHOP Researchers Join Global Team to Take On Solid Cancers

Published on

Jun 29, 2022

in Cornerstone Blog

CHOP Researchers Join Global Team to Take On Solid Cancers

CHOP scientists are part of a Cancer Grand Challenges team receiving $25 million to tackle solid tumors.

Jennifer Pogoriler, MD, PhD

Dr. Pogoriler's research focuses on pediatric lung disease and neoplasia. These interests come together in her work on congenital cystic lung lesions and their potential premalignant diagnosis. She collaborates with both clinicians and basic scientists on pediatric cancer research.

E-mail:

pogorilerj [at] chop.edu